Disclosure of the transfers
of value – Italy
The European Federation of Pharmaceutical Industries and Associations (EFPIA) member companies, including LEO Pharma, are required to disclose, by June 30th, transfers of value (TOV) to healthcare professionals and organizations made in the previous year in connection with prescription medicines on an individual named basis (aggregate by exception only).
The disclosure includes, for example, sponsorship of travel and costs for registration with medical congresses, fees to healthcare professionals for speaker arrangements or for moderating events and contributions to healthcare organizations. Transfers of value for activities related to research and development are published in aggregated form.
The disclosure we make yearly, by the end of June, under the EFPIA Code, is related to the transfer of value occurred in the previous year.
We believe that this publication will facilitate a better awareness of how the pharmaceutical industry works with healthcare professionals and organisations, helping improve the healthcare system and putting the patient’s interests first.
Our publication for Italy
The links given below lead to the disclosures for Italy in line with the EFPIA Code and with the Farmindustria Code of Ethics and the notes specifying the methodology we used to enter the data in the report.
The withdrawal of the privacy consent to the publication of the transfer of value and /or the information request concerning the published data will only be handled by writing to the following email address:
All the withdrawal requests of the privacy consent to the publication of economic transfers arriving in verbal form will not be taken into account.